This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: location, two agreeing sources.

Avery Therapeutics

Avery Therapeutics reported $8,468,859 raised in an SEC Form D filed on 2026-09-21. State of the filing: Arizona.

Industry
Biotechnology
Location
Arizona

About

Avery Therapeutics appears in Section 3 of the Raise Track Update of 2026-09-24, which lists new SEC Form D filings. The filing reports $8,468,859 raised and gives Arizona as the state. The industry on the filing is Biotechnology. Filing: https://www.sec.gov/Archives/edgar/data/1708135/000170813526000003/0001708135-26-000003-index.htm

This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.

Funding history

RoundDateAmountLead
Form D 20262026-09-21$8.47M

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/1708135/000170813526000003/0001708135-26-000003-index.htm
    Type: sec filing. Accessed 2026-10-12.
    SEC Form D filed 2026-09-21 by Avery Therapeutics, Inc. Reports $8,468,859 of securities sold. It does not name investors or a round type.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-09-24/
    Type: other verified public source. Accessed 2026-10-12.
    Raise Track Update for 2026-09-24, Section 3 (SEC Form D filings). Lists Avery Therapeutics, state ARIZONA, industry Biotechnology, amount raised 8468859.